Cargando…

Validation of original and alternative fistula risk scores in postoperative pancreatic fistula

BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Youngju, Shin, Sang Hyun, Park, Dae Joon, Kim, Naru, Heo, Jin Seok, Choi, Dong Wook, Han, In Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771591/
https://www.ncbi.nlm.nih.gov/pubmed/31125494
http://dx.doi.org/10.1002/jhbp.638
_version_ 1783455721141043200
author Ryu, Youngju
Shin, Sang Hyun
Park, Dae Joon
Kim, Naru
Heo, Jin Seok
Choi, Dong Wook
Han, In Woong
author_facet Ryu, Youngju
Shin, Sang Hyun
Park, Dae Joon
Kim, Naru
Heo, Jin Seok
Choi, Dong Wook
Han, In Woong
author_sort Ryu, Youngju
collection PubMed
description BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancreaticoduodenectomy (PD). METHODS: From January 2007 to December 2016, 1,771 patients underwent PD for periampullary cancers. POPF was defined and classified according to the 2016 International Study Group for Pancreatic Fistula. All data were reviewed retrospectively. RESULTS: Pathologic diagnosis other than ductal adenocarcinoma (P < 0.001), pancreas duct diameter (P < 0.001), and body mass index (P < 0.001) were independent risk factors for CR‐POPF. Pancreatic texture (P = 0.534) and estimated blood loss (P = 0.827) were not associated with CR‐POPF. The CR‐POPF incidence increased with increasing o‐FRS score (P < 0.001), and also increased statistically significantly with increasing a‐FRS in the higher risk group (P < 0.001). However, the correlations differed. The area under the curve was 0.629 for o‐FRS and 0.622 for a‐FRS. CONCLUSIONS: Both o‐FRS and a‐FRS might reflect CR‐POPF incidence, but some risk factors had no or low statistical significance. Further research is needed to revise the FRS.
format Online
Article
Text
id pubmed-6771591
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67715912019-10-03 Validation of original and alternative fistula risk scores in postoperative pancreatic fistula Ryu, Youngju Shin, Sang Hyun Park, Dae Joon Kim, Naru Heo, Jin Seok Choi, Dong Wook Han, In Woong J Hepatobiliary Pancreat Sci Original Articles BACKGROUND: In 2013, the fistula risk score (FRS) was developed to assess the risk of clinically relevant postoperative pancreatic fistula (CR‐POPF). In 2017, the alternative FRS (a‐FRS) was proposed. The purpose of this study was to validate the original FRS (o‐FRS) and a‐FRS for CR‐POPF in pancreaticoduodenectomy (PD). METHODS: From January 2007 to December 2016, 1,771 patients underwent PD for periampullary cancers. POPF was defined and classified according to the 2016 International Study Group for Pancreatic Fistula. All data were reviewed retrospectively. RESULTS: Pathologic diagnosis other than ductal adenocarcinoma (P < 0.001), pancreas duct diameter (P < 0.001), and body mass index (P < 0.001) were independent risk factors for CR‐POPF. Pancreatic texture (P = 0.534) and estimated blood loss (P = 0.827) were not associated with CR‐POPF. The CR‐POPF incidence increased with increasing o‐FRS score (P < 0.001), and also increased statistically significantly with increasing a‐FRS in the higher risk group (P < 0.001). However, the correlations differed. The area under the curve was 0.629 for o‐FRS and 0.622 for a‐FRS. CONCLUSIONS: Both o‐FRS and a‐FRS might reflect CR‐POPF incidence, but some risk factors had no or low statistical significance. Further research is needed to revise the FRS. John Wiley and Sons Inc. 2019-07-01 2019-08 /pmc/articles/PMC6771591/ /pubmed/31125494 http://dx.doi.org/10.1002/jhbp.638 Text en © 2019 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Ryu, Youngju
Shin, Sang Hyun
Park, Dae Joon
Kim, Naru
Heo, Jin Seok
Choi, Dong Wook
Han, In Woong
Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title_full Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title_fullStr Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title_full_unstemmed Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title_short Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
title_sort validation of original and alternative fistula risk scores in postoperative pancreatic fistula
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771591/
https://www.ncbi.nlm.nih.gov/pubmed/31125494
http://dx.doi.org/10.1002/jhbp.638
work_keys_str_mv AT ryuyoungju validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT shinsanghyun validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT parkdaejoon validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT kimnaru validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT heojinseok validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT choidongwook validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula
AT haninwoong validationoforiginalandalternativefistulariskscoresinpostoperativepancreaticfistula